Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 3.01, 5.02 · 8-K

Launch One Acquisition Corp.

LPAANASDAQEQUITYCurrent

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The information set forth in Item 5.02 of this Current Report on Form 8-K (this “Report”) regarding the resignation of Dr. Rodney A. Ferguson from the board of directors (the “Board”) of Launch One Acquisition Corp. (the “Company”) is incorporated by reference into this Item 3.01. As a result of Dr.…

Filed Nov 9, 2026Accepted Nov 9, 2026, 4:15 PM ESTCIK 2015502Accession 0001213900-26-117530
Share

Company context

Launch One Acquisition Corp. is a company set up to merge with and take public an exciting business in healthcare or technology. Listed on Nasdaq under the ticker LPAA, Launch One is led by experienced leaders who want to support game-changing solutions. For more information, contact Jurgen van de Vyver at jurgen@launchpad.vc.

Current securities

Recent company filings

  1. 10-Q filingNov 16, 2026
  2. SCHEDULE 13G/A - filed by LMR Partners LLP regarding Launch One Acquisition Corp.Nov 16, 2026
  3. SCHEDULE 13G/A - filed by First Trust Capital Management L.P. regarding Launch One Acquisition Corp.Nov 13, 2026
  4. SCHEDULE 13G/A - filed by Magnetar Financial LLC regarding Launch One Acquisition Corp.Nov 13, 2026
  5. SCHEDULE 13G/A - filed by MMCAP International Inc. SPC regarding Launch One Acquisition Corp.Nov 12, 2026

Registered securities in this filing

Launch One Acquisition Corp. · 8-K · Filed 2026-11-09

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant

Symbol
LPAAU
Exchange
NASDAQ
Classification
UNIT
Status
Current
Filing context

Context: From2026-11-042026-11-04_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember

Dimensions: us-gaap:StatementClassOfStockAxis

Class A ordinary shares, par value $0.0001 per share

Symbol
LPAA
Exchange
NASDAQ
Classification
COMMON
Status
Current
Filing context

Context: From2026-11-042026-11-04_custom_ClassOrdinarySharesParValue0.0001PerShareMember

Dimensions: us-gaap:StatementClassOfStockAxis

Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share

Symbol
LPAAW
Exchange
NASDAQ
Classification
WARRANT
Status
Current
Filing context

Context: From2026-11-042026-11-04_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember

Dimensions: us-gaap:StatementClassOfStockAxis

Accession 000121390026117530 · 3 registered-security cover members

Read the exact SEC filing ↗

Disclosure sections

Items 3.01, 5.02

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 3.01Item 3.01 - Notice of Delisting
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The information set forth in Item 5.02 of this Current Report on Form 8-K (this “Report”) regarding the resignation of Dr. Rodney A. Ferguson from the board of directors (the “Board”) of Launch One Acquisition Corp. (the “Company”) is incorporated by reference into this Item 3.01. As a result of Dr. Ferguson’s resignation, the audit committee of the Board (the “Audit Committee”) is comprised of two members, Mr. Atwood and Mr. Rogers, and the Company no longer complies with Nasdaq Listing Rule 5605(c)(2)(A), which requires that the audit committee of a listed company be comprised of at least three members, each of whom must, among other things, be an independent director as defined under the Nasdaq listing rules and meet the criteria for independence set forth in Rule 10A-3(b)(1) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). On December 6, 2026, The Nasdaq Stock Market LLC (“Nasdaq”) notified the Company of such noncompliance. Nasdaq Listing Rule 5605(c)(4)(B) provides that, where a listed company fails to comply with the audit committee composition requirements of Nasdaq Listing Rule 5605(c)(2)(A) due to a single vacancy on the audit committee, the company will have a cure period to regain compliance until the earlier of (i) its next annual meeting of shareholders and (ii) one year from the occurrence of the event that caused the noncompliance; provided, however, that if the next annual meeting of shareholders is held no later than 180 days following the event that caused the vacancy, the company will instead have 180 days from such event to regain compliance. The Company intends to rely on this cure period. The Board intends to appoint a new independent director who satisfies the applicable requirements of the Nasdaq listing rules and Rule 10A-3 under the Exchange Act to serve on the Board and the Audit Committee prior to the expiration of the cure period. As of the date of this Report, no replacement director has been appointed, and there can be no assurance as to the timing of any such appointment. In addition, as a result of Dr. Ferguson’s resignation, the Board is no longer comprised of a majority of independent directors, as required by Nasdaq Listing Rule 5605(b)(1). Nasdaq Listing Rule 5605(b)(1)(A) provides a cure period on substantially the same terms as described above with respect to the Audit Committee. On November 6, 2026, Nasdaq notified the Company of such noncompliance. The Company intends to rely on such cure period and expects to regain compliance with Nasdaq Listing Rule 5605(b)(1) upon the appointment of a new independent director as described above. The compensation committee of the Board is comprised of two members, Mr. Atwood and Mr. Rogers.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 4, 2026, Dr. Rodney A. Ferguson notified the Company of his decision to resign from the Board and as a member of the Audit Committee and the compensation committee of the Board, effective immediately. Dr. Ferguson’s decision to resign was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The information set forth in Item 3.01 of this Report is incorporated by reference into this Item 5.02.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.